1. Pioglitazone as adjuvant therapy in chronic hepatitis C: Sequential rather than concomitant administration with pegylated interferon and ribavirin? 
Lawrence Serfaty, Laetitia Fartoux, Raoul Poupon 
Journal of Hepatology 
Volume 50, Issue 6, Pages (June 2009)
DOI: /j.jhep
Copyright © 2009 European Association for the Study of the Liver Terms and Conditions

2. Fig. 1
Course of HCV RNA level during the first course of peglyated interferon α2a 180μg QW + ribavirin 1000mg QD (PegIFN+Riba) (lower limit of detection 615IU/ml) and during the second course of PegIFN+Riba associated with pioglitazone 45mg/d (lower limit of detection 15IU/ml). Course of homeostasis model assessment (HOMA) index is indicated at the bottom of the figure.
Journal of Hepatology  , DOI: ( /j.jhep )
Copyright © 2009 European Association for the Study of the Liver Terms and Conditions